We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
16 Feb 2023 - 18 Feb 2023

Embolic Protection Device Minimizes Cerebral Damage Risk

By HospiMedica International staff writers
Posted on 17 Mar 2020
Print article
Image: The TriGuard 3 CEP device protects all three aortic arch branches (Photo courtesy of Keystone Heart)
Image: The TriGuard 3 CEP device protects all three aortic arch branches (Photo courtesy of Keystone Heart)
A new cerebral embolic protection (CEP) device deflects debris away from the brain during transcatheter heart procedures.

The Keystone Heart (Caesarea, Israel) TriGuard 3 CEP is a self-positioning, self-stabilizing device designed to protect all three major arteries that supply blood to the brain to minimize risk of cerebral damage during transcatheter aortic valve replacement (TAVR) and other procedures. The device is shaped to accommodate anatomic variations of the aortic arch, and is designed to deploy rapidly and self-position through a small 8F catheter, providing stable, atraumatic protection and simple retrieval upon completion of the procedure.

Formed to withstand potential interface with the TAVR delivery system and other procedure related accessories, TriGuard 3 is composed of a Nitinol frame and a dome-shaped polymeric mesh deflector--with a pore size of 115 x 145 µm--that is at the same flexible and atraumatic, yet robust and sturdy. The CEP device is placed via one of the two femoral artery access ports typically used in TAVR, thereby eliminating the need for a third puncture site.

“Our next generation device, TriGuard 3 incorporates ease-of-use and anatomy independence, while eliminating device and cerebral branch interaction. This is exactly what our investigators have been asking for in a cerebral embolic protection device.” said Chris Richardson, president and CEO of Keystone Heart, LTD. “Taking into consideration the devastating impact of stroke, we are pleased to bring this important technology to patients undergoing any transcatheter heart procedure.”

“We need the right tools to best combat the risk of stroke and neurological damage associated with TAVR and other cardiovascular procedures,” said Professor Jeffrey Moses, MD, director of advanced cardiac therapeutics at St. Francis Heart Center (Roslyn, NY, USA). “Embolic debris resulting from these procedures can have a grave impact on how post-procedure patients function in their daily lives. The new improvements to TriGuard enhance its ability to become the optimal design for cerebral embolic protection.”

New ischemic brain lesions, or “silent” infarcts, occur in more than 90% of TAVR and other endovascular procedures, according to recent research. These ischemic lesions are associated with adverse neurologic and cognitive consequences, as well as dementia, and have also been shown to increase the risk of stroke by two to four times.

Related Links:
Keystone Heart

Gold Supplier
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Medical Software
Bladder Scanner Graphics Workstation Software
Electric Suction Machine
Memory Foam Mattress

Print article



view channel
Image: A novel research study moves the needle on predicting coronary artery disease (Photo courtesy of Pexels)

AI-Enabled ECG Analysis Predicts Heart Attack Risk Nearly as well as CT Scans

Increased coronary artery calcium is a marker of coronary artery disease that can lead to a heart attack. Traditionally, CT scans are used to diagnose buildup of coronary artery calcium, although CT scanners... Read more

Critical Care

view channel
Image: The new biomaterial heals tissues from the inside out (Photo courtesy of UC San Diego)

Groundbreaking Biomaterial Injected Intravenously Repairs Cells and Tissue Damaged by Heart Attack and TBI

Following a heart attack, there is development of scar tissue, which affects muscle function and can result in congestive heart failure. However, there is still no established treatment available for repairing... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Point of Care

view channel
Image: Steripath improves the diagnostic accuracy and timeliness of sepsis test results (Photo courtesy of Magnolia)

All-in-One Device Reduces False-Positive Diagnostic Test Results for Bloodstream Infections

Blood cultures are considered the gold standard diagnostic test for the detection of blood stream infections, such as sepsis. However, positive blood culture results can be frequently wrong, and about... Read more


view channel
Image: The global patient positioning systems market is projected to reach USD 1.7 billion by 2027 (Photo courtesy of Pexels)

Global Patient Positioning Systems Market Driven by Increasing Chronic Diseases

The global patient positioning systems market is projected to grow at a CAGR of 4% from USD 1.4 billion in 2022 to USD 1.7 billion by 2027, driven by increasing technological advancements in medical devices,... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.